Abstract: OBJECTIVE To explore an innovative service model of pharmaceutical follow-up for type 2 diabetic discharge patient using "Internet plus" technology. METHODS Type 2 diabetes discharge patients who were improved by active treatment in endocrinology department of Ningbo Municipal Hospital of Traditional Chinese Medicine had been selected from January 2019 to April 2019, treated with "Internet plus" pharmaceutical follow-up for 3 months. Scores of medication compliance Morisky questionnaire, self-management ability questionnaire of type 2 diabetic discharge patient and changes of comprehensive control index were compared before and after follow-up to evaluate pharmaceutical service effect. RESULTS Followed up for 3 months, the score of "medication compliance" in type 2 diabetic discharge patient went from 1.94±1.32 to 1.09±0.95(P<0.05), and the score of self-management ability questionnaire had improved from 61.91±19.36 to 79.12±13.62(P<0.05). The level of glycated hemoglobin had decreased from (9.49±2.31)% to (6.69±1.49)% (P<0.05); and low density lipoprotein cholesterol had decreased from (2.65±0.95)mmol·L^-1 to (2.22±0.71)mmol·L^-1 (P<0.05). Fasting blood glucose was (6.72±1.38)mmol·L^-1 and (6.79±1.07)mmol·L^-1 before and after follow-up, and there was no significantly difference between them. Baseline fasting glucose leve had been kept on an even keel. CONCLUSION The innovative service model of pharmaceutical follow-up using "Internet plus" technology have significantly improved the medication compliance, self-management ability and diabetes comprehensive control index, expanding the space of pharmaceutical care for clinical pharmacists in medical institutions. "Internet plus" innovative service model of pharmaceutical follow-up is worthy of being generalized in clinical practice.